Cochlear Ltd. (CHEOF)
Cochlear Market Cap: 12.09B for Jan. 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 58.91M |
| Kazia Therapeutics Ltd. | 80.77M |
| Immutep Ltd. | 411.20M |
| Propanc Biopharma, Inc. | 3.570M |
| Mesoblast Ltd. | 2.220B |
Market Cap Related Metrics
| PS Ratio | 7.952 |
| PEG Ratio | 1.907 |
| Price to Free Cash Flow | 141.65 |
| Price | 184.91 |
| Earnings Yield | 2.08% |
| PEGY Ratio | 1.907 |
| Operating PE Ratio | 36.77 |
| Normalized PE Ratio | 47.89 |